Chapter 52. TERMINALLY ILL PATIENT’S RIGHT TO TRY INVESTIGATIONAL DRUGS, BIOLOGICAL PRODUCTS, AND DEVICES
18 sections · 31-52-1 to 31-52-27
Article 1. RIGHT TO TRY
- 31-52-1Short title.
- 31-52-2Legislative findings.
- 31-52-3Definitions.
- 31-52-4Eligibility criteria.
- 31-52-5Written informed consent.
- 31-52-6Manufacturers permitted to make investigational drugs, biological products, or devices available.
- 31-52-7Coverage under health benefit plan permitted but not required.
- 31-52-8Physician immunity from professional sanction.
- 31-52-9State prohibited from blocking eligible patient access.
- 31-52-10Statutory construction; immunity from liability.
Article 2. INDIVIDUALIZED INVESTIGATIONAL TREATMENT
- 31-52-20Definitions.
- 31-52-21Physician documentation of eligibility.
- 31-52-22Requirements for written informed consent.
- 31-52-23Request to manufacturer.
- 31-52-24Costs; provision of services.
- 31-52-25Physician protection from administrative retaliation.
- 31-52-26Prohibition on blocking access.
- 31-52-27Limitation on liability; construction of article.